MedTrace Logo

Prognosis of Dental Implants in Patients With Primary Sjögren's Syndrome

NCT04960605 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2023-12-01

No results posted yet for this study

Summary

Primary Sjögren's Syndrome (PSS) is a chronic autoimmune inflammatory disease primarily involving the salivary and lacrimal glands. Few data exist regarding survival and success rate of dental implants in patients with PSS. Although a previous study suggest lower success rate for dental implants we hypothesize that dental implants have similar survival and success rate in PSS as healthy controls.

The purpose of the present study was to evaluate the long-term survival and success rate of dental implants in patients with PSS compared to the healthy controls.

Conditions

  • Dental Implant
  • Primary Sjögren Syndrome

Interventions

PROCEDURE

Dental implants

Treatment of the toothless regions with dental implants

Sponsors & Collaborators

  • ITI Foundation

    collaborator INDUSTRY

  • Gigtforeningen

    collaborator OTHER

  • Rigshospitalet, Denmark

    collaborator OTHER

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Mandana Hosseini · University of Copenhagen

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2023-10-27
Completion
2023-10-27

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04960605 on ClinicalTrials.gov